← Back to Clinical Trials
Recruiting NCT06839950

NCT06839950 Sensory Profile and Early Clinical Signs of Calm Room Users

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06839950
Status Recruiting
Phase
Sponsor Centre Hospitalier Esquirol
Condition Psychotic Disorders
Study Type OBSERVATIONAL
Enrollment 80 participants
Start Date 2023-12-19
Primary Completion 2027-12-19

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
Calm room

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 80 participants in total. It began in 2023-12-19 with a primary completion date of 2027-12-19.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This descriptive study aims primarily to characterize the sensory profile of patients in a closed psychiatric hospital unit who use a calming room. The main questions it aims to answer are : * Could sensory information processing disorders be the cause of distress and tension in these patients? * Could users of the calming room present extreme sensory processing profiles, characterized by either hypersensitivity or hyposensitivity ? Participants will answer a survey to determine their the sensory profile. Participants can already use the calming room as part of their regular medical care and they will answer surveys before and after each use.

Eligibility Criteria

Inclusion Criteria: * Gender and Age: Male or female, aged 18 to 65 * Hospitalization: Admitted to the closed hospitalization unit for less than 10 days * Social security: Affiliated or beneficiary of a social security system * Consent: Free, informed, and written consent, signed by the participant and/or their legal representative (for participants under protection measures) and the investigator (at the latest on the day of inclusion and before any research-related examination). Exclusion Criteria: * Inability to understand information related to the study * Proven sensory disability * Dementia * Pregnancy * Lack of social protection * Previous Participation in this research protocol (in the case of a new hospitalization) * Expression abilities incompatible with completing the AASP Scale (e.g., french language comprehension issues, mute individuals, patients in restraint and/or therapeutic isolation)

Contact & Investigator

Central Contact

Aude Paquet, PhD in Psychology

✉ aude.paquet@ch-esquirol-limoges.fr

📞 +33 5-55-43-11-27

Frequently Asked Questions

Who can join the NCT06839950 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Psychotic Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06839950 currently recruiting?

Yes, NCT06839950 is actively recruiting participants. Contact the research team at aude.paquet@ch-esquirol-limoges.fr for enrollment information.

Where is the NCT06839950 trial being conducted?

This trial is being conducted at Limoges, France.

Who is sponsoring the NCT06839950 clinical trial?

NCT06839950 is sponsored by Centre Hospitalier Esquirol. The trial plans to enroll 80 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology